Get the Stockscreener App
4.58
1.33%
0.06
908 Devices Inc stock is traded at $4.58, with a volume of 496.05K.
It is up +1.33% in the last 24 hours and up +1.10% over the past month.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
See More
Previous Close:
$4.52
Open:
$4.6
24h Volume:
496.05K
Relative Volume:
0.51
Market Cap:
$164.24M
Revenue:
$59.63M
Net Income/Loss:
$-72.21M
P/E Ratio:
-2.181
EPS:
-2.1
Net Cash Flow:
$-30.85M
1W Performance:
-18.51%
1M Performance:
+1.10%
6M Performance:
+91.63%
1Y Performance:
-33.43%
1-Day Range:
$4.51
$4.71
1-Week Range:
$4.20
$6.03
52-Week Range:
$1.81
$7.03
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
645 SUMMER STREET, BOSTON
Compare MASS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
4.58 | 200.86M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-07-23 | Initiated | Stephens | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jan-12-21 | Initiated | Cowen | Outperform |
| Jan-12-21 | Initiated | SVB Leerink | Outperform |
| Jan-12-21 | Initiated | Stifel | Buy |
| Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
Stifel Financial Corp Invests $52,000 in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Inc. (NASDAQ:MASS) Position Reduced by Dimensional Fund Advisors LP - Defense World
Leerink Partnrs Increases Earnings Estimates for 908 Devices - Defense World
Director’s Bold Move: Major Stock Purchase at 908 Devices! - TipRanks
908 Devices Inc. Earnings Call: Growth Amid Challenges - TipRanks
CEO’s Bold Stock Purchase Signals Confidence in 908 Devices - TipRanks
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates - MSN
908 Devices Inc. (NASDAQ:MASS) Q1 2025 Earnings Call Transcript - Insider Monkey
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook - BioSpace
908 Devices Inc (MASS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Losses - Yahoo Finance
908 Devices (MASS) Anticipates Revenue Growth for 2025 | MASS St - GuruFocus
908 Devices Inc. Reports Strong Q1 2025 Growth - TipRanks
MASS Reports Solid Start to 2025 with Revenue Near Expectations - GuruFocus
908 Devices Inc Reports Q1 2025 Earnings: EPS Matches Estimate a - GuruFocus
Earnings call transcript: 908 Devices Q1 2025 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa
Transcript : 908 Devices Inc., Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com
Earnings call transcript: 908 Devices Q1 2025 beats EPS forecast, stock rises - Investing.com Australia
908 Devices Inc. SEC 10-Q Report - TradingView
908 Devices Q1 2025 slides reveal 59% revenue growth following portfolio divestiture - Investing.com Australia
908 Devices Reports First Quarter 2025 Financial Results and Rei - GuruFocus
908 Devices earnings beat by $1.52, revenue topped estimates - Investing.com
908 Devices Reports First Quarter 2025 Financial Results - TradingView
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook | MASS Stock News - GuruFocus
908 Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Hsbc Holdings PLC Has $46,000 Stock Position in 908 Devices Inc. (NASDAQ:MASS) - Defense World
What To Expect From 908 Devices Inc (MASS) Q1 2025 Earnings - GuruFocus
908 Devices (NASDAQ:MASS) Given “Sell (D-)” Rating at Weiss Ratings - Defense World
908 Devices Inc. (MASS): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - MSN
Marshall Wace LLP Purchases Shares of 38,500 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
908 Devices (MASS) to Release Quarterly Earnings on Tuesday - Defense World
LPL Financial LLC Grows Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
Geode Capital Management LLC Raises Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection - 01net
Why 908 Devices Inc. (MASS) is Surging in 2025 - Insider Monkey
XTX Topco Ltd Buys Shares of 52,196 908 Devices Inc. (NASDAQ:MASS) - Defense World
Repligen Corporation Q1 2025 Financial Results - TradingView
908 Devices receives $2M order from the Texas Department of Public Safety for drug detection and mitigation - Police1
908 Devices (NASDAQ:MASS) Receives “Sell (D-)” Rating from Weiss Ratings - Defense World
Market Insights: 908 Devices Inc (MASS)’s Notable Drop of -4.59, Closing at 5.40 - DWinneX
MASS’s Market Whiplash: 157.27% YTD Rise, 24.94% Rise in 30 Days - investchronicle.com
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - Yahoo Finance
908 Devices Inc. Receives $2 Million Order from the Texas Department of Public Safety for Drug Detection and Mitigation - marketscreener.com
Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed - Nasdaq
An Analysis Of 908 Devices Inc (MASS) Stock - Marketing Sentinel
MASS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - 01net
908 Devices Gets $2 Million Order From Texas for Drug Detection Tools - marketscreener.com
908 Devices (MASS) Secures $2M Order from Texas Department of Pu - GuruFocus
908 Devices rises after $2 million order from Texas Department of Public Safety - TradingView
908 Devices (MASS) Secures $2M Order from Texas Department of Public Safety | MASS Stock News - GuruFocus
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
908 Devices Inc Stock (MASS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Knopp Kevin J. | President and CEO |
May 14 '25 |
Buy |
4.32 |
15,000 |
64,788 |
707,733 |
| Griffith Joseph H. IV | Chief Financial Officer |
Feb 03 '25 |
Sale |
2.34 |
10,236 |
23,985 |
109,870 |
| Turner Michael S. | Chief Legal & Admin Officer |
Feb 03 '25 |
Sale |
2.33 |
9,672 |
22,499 |
24,603 |
| Knopp Kevin J. | President and CEO |
Feb 03 '25 |
Sale |
2.32 |
16,001 |
37,109 |
692,733 |
| Brown Christopher D. | Chief Product Officer |
Feb 03 '25 |
Sale |
2.34 |
7,767 |
18,191 |
962,122 |
| Brown Christopher D. | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
1.58 |
55,131 |
87,107 |
946,453 |
| Knopp Kevin J. | President and CEO |
Dec 13 '24 |
Option Exercise |
1.63 |
158,044 |
257,771 |
667,025 |
| Brown Christopher D. | Chief Product Officer |
Aug 07 '24 |
Option Exercise |
1.58 |
6,328 |
9,998 |
891,322 |
| Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
0.85%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):